The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The immuno-oncology drugs market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 14%, as per The Business Research Company’s market report!

Read More On The Immuno-Oncology Drugs Market Report 2022 – https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

The Immuno-Oncology Drugs Market Size In 2022 And Forecast

The global immuno-oncology drugs market is expected to grow from $60.32 billion in 2021 to $70.59 billion in 2022 at a compound annual growth rate (CAGR) of 17.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The immuno-oncology drugs market is expected to reach $120.37 billion in 2026 at a CAGR of 14.3%.

The immuno-oncology drugs market consists of sales of immuno-oncology drugs used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce immuno-oncology drugs for cancer treatment.

Request for A Sample Of The Global Immuno-Oncology Drugs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp

Rise In Cancer Incidence Rate Globally Is Driving The Growth Of The Immuno-Oncology Drugs Market

According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the immune-oncology drugs market over the coming years.

Competitive Landscape And The Regional Analysis Of The Immuno-Oncology Drugs Market

Major players in the immuno-oncology drugs market are Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG and AbbVie Inc.

The Immuno-Oncology Drugs Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the immuno-oncology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the immuno-oncology drugs market.

Product Innovation – A Key Trend In The Immuno-Oncology Drugs Market

Companies in the immuno-oncology drugs market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive immuno-oncology drugs market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as with academic and research institutions in this market by way of partnerships, and in- or out-licensing deals, this trend has been increasing over recent years.

Immuno-Oncology Drugs Market Segmentation By The Business Research Company

1) By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others

2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes

Here Are Some Reports Related To The Immuno-Oncology Drugs Market –

Oncology Devices Global Market Report 2022

Oncology Drugs Global Market Report 2022

Oncology Drugs Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: